Skip to main content

Table 2 Contingency table showing the breast tumors included in our study categorized according to the cutoff points established for each test (as described in Material and Methods).

From: Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer

FISH\PCR

-

+

-

32

2

+

1

4